Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DIGNAM, James")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 23 of 23

  • Page / 1
Export

Selection :

  • and

Choice and Interpretation of Statistical Tests Used When Competing Risks Are PresentDIGNAM, James J; KOCHERGINSKY, Maria N.Journal of clinical oncology. 2008, Vol 26, Num 24, pp 4027-4034, issn 0732-183X, 8 p.Article

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel project B-14 randomized trialFISHER, Bernard; DIGNAM, James; BRYANT, John et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 9, pp 684-690, issn 0027-8874Article

The Use and Interpretation of Competing Risks Regression ModelsDIGNAM, James J; QIANG ZHANG; KOCHERGINSKY, Masha et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2301-2308, issn 1078-0432, 8 p.Article

Estrogen receptor a, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancersMINJIE WEI; JINHUA XU; DIGNAM, James et al.Breast cancer research and treatment. 2008, Vol 111, Num 1, pp 113-120, issn 0167-6806, 8 p.Article

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomyMINJIE WEI; GRUSHKO, Tatyana A; OLOPADE, Olufunmilayo I et al.Cancer research (Baltimore). 2005, Vol 65, Num 23, pp 10692-10699, issn 0008-5472, 8 p.Article

A Multiresolution Hazard Model for Multicenter Survival Studies : Application to Tamoxifen Treatment in Early Stage Breast CancerBOUMAN, Peter; MENG, Xiao-Li; DIGNAM, James et al.Journal of the American Statistical Association. 2007, Vol 102, Num 480, pp 1145-1157, issn 0162-1459, 13 p.Article

Prognosis and treatment of patients with Breast tumors of one centimeter or less and negative axillary lymph nodesFISHER, Bernard; DIGNAM, James; TAN-CHIU, Elizabeth et al.Journal of the National Cancer Institute. 2001, Vol 93, Num 2, pp 112-120, issn 0027-8874Article

Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast CancerDEZHENG HUO; IKPATT, Francis; MALAKA, David et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4515-4521, issn 0732-183X, 7 p.Article

A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablationMOHILE, Supriya G; BYLOW, Kathryn; DALE, William et al.Cancer. 2007, Vol 109, Num 4, pp 802-810, issn 0008-543X, 9 p.Article

Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the national surgical adjuvant breast and bowel project experienceFISHER, Bernard; LAND, Stephanie; MAMOUNAS, Eleftherios et al.Seminars in oncology. 2001, Vol 28, Num 4, pp 400-418, issn 0093-7754Article

Multiple imputation methods for inference on cumulative incidence with missing cause of failureLEE, Minjung; CRONIN, Kathleen A; GAIL, Mitchell H et al.Biometrical journal. 2011, Vol 53, Num 6, pp 974-993, issn 0323-3847, 20 p.Article

Hormone Replacement Therapy and Breast Cancer: Heterogeneous Risks by Race, Weight, and Breast DensityNINGQI HOU; SUSAN HONG; WENLI WANG et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 18, pp 1365-1372, issn 0027-8874, 8 p.Article

Colorectal cancer model of health disparities : Understanding mortality differences in minority populationsPOLITE, Blase N; DIGNAM, James J; OLOPADE, Olufunmilayo I et al.Journal of clinical oncology. 2006, Vol 24, Num 14, pp 2179-2187, issn 0732-183X, 9 p.Article

Mammographic density and breast cancer after ductal carcinoma in situHABEL, Laurel A; DIGNAM, James J; LAND, Stephanie R et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 19, pp 1467-1472, issn 0027-8874, 6 p.Article

Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trialsDIGNAM, James J; YUNRONG YE; COLANGELO, Linda et al.Journal of clinical oncology. 2003, Vol 21, Num 3, pp 413-420, issn 0732-183X, 8 p.Article

Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancerDIGNAM, James J; DUKIC, Vanja; ANDERSON, Stewart J et al.Breast cancer research and treatment. 2009, Vol 116, Num 3, pp 595-602, issn 0167-6806, 8 p.Article

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancerDIGNAM, James J; WIEAND, Kelly; JOHNSON, Karen A et al.Breast cancer research and treatment. 2006, Vol 97, Num 3, pp 245-254, issn 0167-6806, 10 p.Article

Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancerDIGNAM, James J; POLITE, Blase N; YOTHERS, Greg et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 22, pp 1647-1654, issn 0027-8874, 8 p.Article

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27MAMOUNAS, Eleftherios P; ANDERSON, Stewart J; DIGNAM, James J et al.Journal of clinical oncology. 2012, Vol 30, Num 32, pp 3960-3966, issn 0732-183X, 7 p.Article

Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast CancerANDERSON, Stewart J; WAPNIR, Irene; DIGNAM, James J et al.Journal of clinical oncology. 2009, Vol 27, Num 15, pp 2466-2473, issn 0732-183X, 8 p.Article

Is patient travel distance associated with survival on phase II clinical trials in oncology?LAMONT, Elizabeth B; HAYREH, Davinder; PICKETT, Kate E et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 18, pp 1370-1375, issn 0027-8874, 6 p.Article

MYC is amplified in BRCA1-associated breast cancersGRUSHKO, Tatyana A; DIGNAM, James J; SVEEN, Lise et al.Clinical cancer research. 2004, Vol 10, Num 2, pp 499-507, issn 1078-0432, 9 p.Article

Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck CancerCOHEN, Ezra E. W; HARAF, Daniel J; WITT, Mary Ellyn et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3336-3343, issn 0732-183X, 8 p.Article

  • Page / 1